Immunology

Immunogen dynamin binding protein Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the

Human DNA methyltransferase 1 (Dnmt1) is a 1616 amino acids protein the N-terminal two-thirds of the protein is considered to be the regulatory domain, while the C-terminal region contains the catalytic domain. In humans, the gene encodes a DNA

In humans, the gene encodes a DNA (cytosine-5)-methyltransferase with 1616 amino acids. The N-terminal contains the regulatory domain, while the C-terminal region contains the catalytic domain.

DNMT1 (DNA (cytosine-5-)-methyltransferase 1) is mainly responsible for the DNA methyltransferase activity during replication. It is composed of CXXC region (C is cysteine X is any amino acid), tandem bromo-adjacent homology (BAH1/2) and

DNA (cytosine-5)-methyltransferase 1 (UniProt: P26358 also known as EC: 2.1.

DNA (cytosine-5)-methyltransferase 1 (UniProt: P26358 also known as EC: 2.1.

Immunogen DNA recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most

DNMT3B is a DNA methyltransferase that is expressed in neural progenitor cells. DNMT3B enzyme regulates DNA methylation patterns during growth.

Immunogen DNA (cytosine-5-)-methyltransferase 3-like Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Immunogen DNA (cytosine-5-)-methyltransferase 3-like Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive

Immunogen double C2-like domains, alpha Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in

Dedicator of cytokinesis protein 1 (DOCK1), also termed as the DOCK180 gene, is mapped to human chromosome 10q26.2.